Caricamento...
Efficacy and Safety of Docetaxel Plus Prednisolone Chemotherapy for Metastatic Hormone-Refractory Prostate Adenocarcinoma: Single Institutional Study in Korea
PURPOSE: To assess the efficacy and safety of treating Korean patients with metastatic hormone-refractory prostate cancer (HRPC) using docetaxel plus prednisolone chemotherapy. MATERIALS AND METHODS: This was a retrospective cohort study performed in 98 patients with metastatic HRPC between October...
Salvato in:
Autori principali: | , , , , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Korean Cancer Association
2010
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848748/ https://ncbi.nlm.nih.gov/pubmed/20369046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.1.12 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|